Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

"Natural History" Study of Choroideremia

Phase: N/A Priority: Normal
NCT ID: NCT02994368 Org: User:
Start: 12/31/16 End: 10/31/21 Due: 10/31/22

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT06864988 Org: User:
Start: 03/03/25 End: 06/30/28 Due: 06/30/29

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT05197270 Org: User:
Start: 12/09/21 End: 01/31/31 Due: 01/31/32

4D-310 in Adults With Fabry Disease and Cardiac Involvement

Phase: N/A Priority: Normal
NCT ID: NCT05629559 Org: User:
Start: 10/16/22 End: 06/30/30 Due: 06/30/31

4D-710 in Adult Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05248230 Org: User:
Start: 03/29/22 End: 01/31/30 Due: 01/31/31

4D-150 in Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT05930561 Org: User:
Start: 08/09/23 End: 07/01/28 Due: 07/01/29

Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia

Phase: N/A Priority: Normal
NCT ID: NCT04483440 Org: User:
Start: 06/02/20 End: 08/31/27 Due: 08/31/28

An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT04519749 Org: User:
Start: 09/01/20 End: 06/30/30 Due: 06/30/31

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

Phase: N/A Priority: Normal
NCT ID: NCT04517149 Org: User:
Start: 06/09/20 End: 05/31/29 Due: 05/31/30